1. Frame JD, Baldwin Jr JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of
man from West Africa. Am J Trop Med Hyg. 1970;19:670–676.
2. Mylne AQ, Pigott DM, Longbottom J, Shearer F, Duda KA, Messina JP, et al. Mapping
the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg. 2015;109:483–492.
3. Sogoba N, Feldmann H, Safronetz D. Lassa fever in West Africa: evidence for an
expanded region of endemicity. Zoonoses Public Health. 2012;59:43–47.
4. Han BA, Schmidt JP, Bowden SE, Drake JM. Rodent reservoirs of future zoonotic diseases.
Proc Natl Acad Sci. 2015;112:7039–7044.
5. Bonwitt J, Sáez AM, Lamin J, Ansumana R, Dawson M, Buanie J, et al. At home with
Mastomys and Rattus: human-rodent interactions and potential for primary transmission
of Lassa virus in domestic spaces. Am J Trop Med Hyg. 2017;96:935–943.
6. Mehand MS, Al Shorbaji F, Millett P, Murgue B. The WHO R&D Blueprint: 2018 review
of emerging infectious diseases requiring urgent research and development efforts.
Antiviral Res. 2018;
7. ECDC. European Centre for Disease Prevention and Control (ECDC). Lassa fever in
Nigeria, Benin, Togo - Recherche Google. 2016.
8. Brosh-Nissimov T. Lassa fever: another threat from West Africa. Disaster Mil Med.
2016;2:8.
9. Shah N, Kuriansky J. The impact and trauma for healthcare workers facing the Ebola
epidemic. Psychosoc Asp Deadly Epidemic What Ebola Has Taught Us Holist Heal ABC-CLIO
LLC St Barbara Calif. 2016;91–109.
10. Shehu NY, Gomerep SS, Isa SE, Iraoyah KO, Mafuka J, Bitrus N, et al. Lassa Fever
2016 Outbreak in Plateau State, Nigeria—The Changing Epidemiology and Clinical Presentation.
Front Public Health. 2018;6.
11. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2:
a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern
Med. 2011;155:529–536.
12. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis
of binomial data. Arch Public Health. 2014;72:39.
13. Emmerich P, Günther S, Schmitz H. Strain-specific antibody response to Lassa virus
in the local population of west Africa. J Clin Virol. 2008;42:40–44.
14. Fichet-Calvet E, Lecompte E, Koivogui L, Soropogui B, Doré A, Kourouma F, et al.
Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea,
West Africa. Vector-Borne Zoonotic Dis. 2007;7:119–128.
15. Demby AH, Inapogui A, Kargbo K, Koninga J, Kourouma K, Kanu J, et al. Lassa fever
in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals.
Vector Borne Zoonotic Dis. 2001;1:283–297.
16. Lecompte E, Fichet-Calvet E, Daffis S, Koulémou K, Sylla O, Kourouma F, et al.
Mastomys natalensis and lassa fever, West Africa. Emerg Infect Dis. 2006;12:1971.
17. Kernéis S, Koivogui L, Magassouba N, Koulemou K, Lewis R, Aplogan A, et al. Prevalence
and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea:
a cross-sectional study. PLoS Negl Trop Dis. 2009;3:e548.
18. Klempa B, Koulemou K, Auste B, Emmerich P, Thomé-Bolduan C, Günther S, et al.
Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus
antibodies in Upper Guinea, West Africa. Trop Med Int Health TM IH. 2013;18:366–71.
19. Lukashevich IS, Clegg JCS, Sidibe K. Lassa virus activity in Guinea: Distribution
of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant
antigen. J Med Virol. 1993;40:210–217.
20. Coulibaly-N’Golo D, Allali B, Kouassi SK, Fichet-Calvet E, Becker-Ziaja B, Rieger
T, et al. Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus
from Côte d’Ivoire: implications for evolution of arenaviruses in Africa. PloS One.
2011;6:e20893.
21. Kouadio L, Nowak K, Akoua-Koffi C, Weiss S, Allali BK, Witkowski PT, et al. Lassa
virus in multimammate rats, Côte d’Ivoire, 2013. Emerg Infect Dis. 2015;21:1481.
22. Akoua-Koffi C, Ter JM, Legros D, Akran V, Aidara M, Nahounou N, et al. Detection
of anti-Lassa antibodies in the Western Forest area of the Ivory Coast. Med Trop Rev
Corps Sante Colon. 2006;66:465–468.
23. Yalley-Ogunro JE, Frame JD, Hanson AP. Endemic Lassa fever in Liberia. VI. Village
serological surveys for evidence of Lassa virus activity in Lofa County, Liberia.
Trans R Soc Trop Med Hyg. 1984;78:764–770.
24. Hamblion EL, Raftery P, Wendland A, Dweh E, Williams GS, George RNC, et al. The
challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected
setting. Int J Infect Dis. 2018;66:65–73.
25. Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, Fischer ER, et al. Detection
of Lassa virus, Mali. Emerg Infect Dis. 2010;16:1123.
26. Safronetz D, Sogoba N, Lopez JE, Maiga O, Dahlstrom E, Zivcec M, et al. Geographic
distribution and genetic characterization of Lassa virus in sub-Saharan Mali. PLoS
Negl Trop Dis. 2013;7:e2582.
27. Sogoba N, Rosenke K, Adjemian J, Diawara SI, Maiga O, Keita M, et al. Lassa virus
seroprevalence in sibirilia commune, bougouni district, southern mali. Emerg Infect
Dis. 2016;22:657.
28. Asogun DA, Adomeh DI, Ehimuan J, Odia I, Hass M, Gabriel M, et al. Molecular diagnostics
for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from
two years of laboratory operation. PLoS Negl Trop Dis. 2012;6:e1839.
29. Ehichioya DU, Asogun DA, Ehimuan J, Okokhere PO, Pahlmann M, Ölschläger S, et
al. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005–2008.
Trop Med Int Health. 2012;17:1001–1004.
30. Bajani MD, Tomori O, Rollin PE, Harry TO, Bukbuk ND, Wilson L, et al. A survey
for antibodies to Lassa virus among health workers in Nigeria. Trans R Soc Trop Med
Hyg. 1997;91:379–381.
31. Oloniniyi OK, Unigwe US, Okada S, Kimura M, Koyano S, Miyazaki Y, et al. Genetic
characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern
Nigeria. PLoS Negl Trop Dis. 2018;12:e0006971.
32. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever
antibodies in Nigerian populations. Am J Trop Med Hyg. 1988;38:407–410.
33. Bukbuk DN, Fukushi S, Tani H, Yoshikawa T, Taniguchi S, Iha K, et al. Development
and validation of serological assays for viral hemorrhagic fevers and determination
of the prevalence of Rift Valley fever in Borno State, Nigeria. Trans R Soc Trop Med
Hyg. 2014;108:768–773.
34. Saluzzo JF, Adam F, McCormick JB, Digoutte JP. Lassa fever virus in Senegal. J
Infect Dis. 1988;157:605–605.
35. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of
the epidemiology and ecology of Lassa fever. J Infect Dis. 1987;155:437–444.
36. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, et al. Acute
sensorineural deafness in Lassa fever. Jama. 1990;264:2093–2096.
37. Dahmane A, van Griensven J, Van Herp M, Van den Bergh R, Nzomukunda Y, Prior J,
et al. Constraints in the diagnosis and treatment of Lassa Fever and the effect on
mortality in hospitalized children and women with obstetric conditions in a rural
district hospital in Sierra Leone. 2014 [cited 2019 Apr 23]; Available from: https://fieldresearch.msf.org/handle/10144/315033
38. Attinsounon CA, Ibara BRO, Alassani A, Adé S, Saké K, Kakaï CG, et al. Report
of a fatal case of Lassa fever in Parakou in 2018: clinical, therapeutic and diagnostic
aspects. BMC Infect Dis. 2018;18:667.
39. van der Heide RM. A patient with Lassa fever from Upper Volta, diagnosed in the
Netherlands. Ned Tidjschrift Voor Geneeskd. 1982;126:566–569.
40. Kyei NN, Abilba MM, Kwawu FK, Agbenohevi PG, Bonney JH, Agbemaple TK, et al. Imported
Lassa fever: a report of 2 cases in Ghana. BMC Infect Dis. 2015;15:217.
41. Bonney JH, Nyarko EO, Ohene S-A, Amankwa J, Ametepi RK, Nimo-Paintsil SC, et al.
Molecular confirmation of Lassa fever imported into Ghana. Afr J Lab Med. 2016;5:1–6.
42. Dzotsi EK, Ohene SA, Asiedu-Bekoe F, Amankwa J, Sarkodie B, Adjabeng M, et al.
The first cases of Lassa fever in Ghana. Ghana Med J. 2012;46:166.
43. Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, et al. Favipiravir
and ribavirin treatment of epidemiologically linked cases of Lassa fever. Clin Infect
Dis. 2017;65:855–859.
44. Whitmer SL, Strecker T, Cadar D, Dienes H-P, Faber K, Patel K, et al. New lineage
of Lassa virus, Togo, 2016. Emerg Infect Dis. 2018;24:599.
45. Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: an overview.
J Vector Borne Dis. 2007;44:1.
46. Fichet-Calvet E, Rogers DJ. Risk maps of Lassa fever in West Africa. PLoS Negl
Trop Dis. 2009;3:e388.
47. Manning JT, Forrester N, Paessler S. Lassa virus isolates from Mali and the Ivory
Coast represent an emerging fifth lineage. Front Microbiol. 2015; 6: 1037. 2015.
48. Lalis A, Leblois R, Lecompte E, Denys C, ter Meulen J, Wirth T. The impact of
human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa.
PLoS One. 2012;7:e37068.
49. Fichet-Calvet E, Ölschläger S, Strecker T, Koivogui L, Becker-Ziaja B, Camara
AB, et al. Spatial and temporal evolution of Lassa virus in the natural host population
in Upper Guinea. Sci Rep. 2016;6:21977.
50. Olayemi A, Cadar D, Magassouba N, Obadare A, Kourouma F, Oyeyiola A, et al. New
hosts of the Lassa virus. Sci Rep. 2016;6:25280.
51. Agbonlahor DE, Erah A, Agba IM, Oviasogie FE, Ehiaghe AF, Wankasi M, et al. Prevalence
of Lassa virus among rodents trapped in three South-South States of Nigeria. J Vector
Borne Dis. 2017;54:146.
52. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social
consequences. Bmj. 2003;327:1271–1275.
53. Hallam HJ, Hallam S, Rodriguez SE, Barrett AD, Beasley DW, Chua A, et al. Baseline
mapping of Lassa fever virology, epidemiology and vaccine research and development.
NPJ Vaccines. 2018;3:11.
54. Tambo E, Adetunde OT, Olalubi OA. Re-emerging Lassa fever outbreaks in Nigeria:
Re-enforcing “One Health” community surveillance and emergency response practice.
Infect Dis Poverty. 2018;7:37.